- Home
- KLRS vs HFBL Comparison
KLRS vs HFBL Comparison
Compare KLRS & HFBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- HFBL
- Stock Information
- Founded
- KLRS 2019
- HFBL 1924
- Country
- KLRS United States
- HFBL United States
- Employees
- KLRS N/A
- HFBL N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- HFBL Savings Institutions
- Sector
- KLRS Health Care
- HFBL Finance
- Exchange
- KLRS Nasdaq
- HFBL Nasdaq
- Market Cap
- KLRS 46.0M
- HFBL 41.3M
- IPO Year
- KLRS N/A
- HFBL N/A
- Fundamental
- Price
- KLRS $4.39
- HFBL $13.67
- Analyst Decision
- KLRS Strong Buy
- HFBL
- Analyst Count
- KLRS 2
- HFBL 0
- Target Price
- KLRS $23.00
- HFBL N/A
- AVG Volume (30 Days)
- KLRS 728.6K
- HFBL 2.0K
- Earning Date
- KLRS 11-15-2025
- HFBL 10-28-2025
- Dividend Yield
- KLRS N/A
- HFBL 3.85%
- EPS Growth
- KLRS N/A
- HFBL 6.78
- EPS
- KLRS N/A
- HFBL 1.26
- Revenue
- KLRS N/A
- HFBL $20,802,000.00
- Revenue This Year
- KLRS N/A
- HFBL N/A
- Revenue Next Year
- KLRS N/A
- HFBL N/A
- P/E Ratio
- KLRS N/A
- HFBL $10.85
- Revenue Growth
- KLRS N/A
- HFBL 1.50
- 52 Week Low
- KLRS $2.14
- HFBL $11.75
- 52 Week High
- KLRS $24.15
- HFBL $14.25
- Technical
- Relative Strength Index (RSI)
- KLRS 58.92
- HFBL 56.53
- Support Level
- KLRS $3.49
- HFBL $13.34
- Resistance Level
- KLRS $5.30
- HFBL $13.44
- Average True Range (ATR)
- KLRS 0.77
- HFBL 0.08
- MACD
- KLRS -0.01
- HFBL 0.02
- Stochastic Oscillator
- KLRS 23.97
- HFBL 97.06
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.